Madhukar Rainbow Children’s Hospital, New Delhi, has successfully treated an 8-year-old boy diagnosed with relapsed Ewing’s ...

Ewing sarcoma is one of the most common types of bone cancer found in children and teenagers. When the cancer spreads to ...

HealthDay News — For young patients with primary multimetastatic Ewing sarcoma, pazopanib is well-tolerated and effective, according to a study published online Oct. 22 in Frontiers in Oncology.

The family of 19-year-old Layton Deakin Geanokopoulos is calling on the community to rally behind them as they prepare to ...

A 12-year-old girl died of a rare cancer which her parents spotted when they watched her brush her teeth. While Beth Phelps ...

A Garsington dad has paddle boarded across the English Channel in memory of his niece to raise £15,000 for childhood cancer research.

Ewing sarcoma is one of the most common bone cancers seen in children, and if it spreads, it can be deadly. One study found ...

Michael Perez has been running with a football for as long as he can remember. However, he received a medical diagnosis that threatened to cut his career short. In July of 2024, he was diagnosed with ...

Inhibrx Biosciences, Inc. reports strong phase 2 results for ozekibart in chondrosarcoma, with new cancer data and key approvals ahead. Click for my INBX update.

Ozekibart meets its primary endpoint in chondrosarcoma, demonstrating a statistically significant and clinically meaningful improvement in median progression-free survival compared to placebo Key ...

Inhibrx Biosciences said on Thursday its experimental drug helped slow the progression of a rare and aggressive bone cancer in a mid-stage trial, sending its shares surging over 70% in extended ...

SAN DIEGO, Oct. 23, 2025 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapeutics for ...